Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 74Specimen Handling 69Cyclophosphamide 61Cytarabine 52Biopsy 51fludarabine 45Azacitidine 38Rituximab 28fludarabine phosphate 22Methotrexate 22Vincristine 21Magnetic Resonance Spectroscopy 21blinatumomab 20Daunorubicin 20Prednisone 19Dexamethasone 17ibrutinib 16Whole-Body Irradiation 16Injections 16decitabine and cedazuridine drug combination 15Tacrolimus 14Mycophenolic Acid 14Melphalan 14Doxorubicin 14Busulfan 14obinutuzumab 13merphos 13acalabrutinib 13Mercaptopurine 13Granulocyte Colony-Stimulating Factor 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pneumococcal Vaccines × Other hematologic neoplasm × 30 days × Clear all
NCT01351896 2026-05-27

Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
49 enrolled 34 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡